[Radiotherapy of oligometastatic pelvic node relapses in patients with prostate cancer].

[Radiotherapy of oligometastatic pelvic node relapses in patients with prostate cancer]. Cancer Radiother. 2017 Aug 25;: Authors: Supiot S, Doré M, Rio E Abstract The Oligopelvis 2 studies is based on the assumption that salvage pelvic radiotherapy may prolong the interval between the first and the second intermittent hormone therapy sequence in pelvic lymph node oligometastatic prostate cancer. This phase 3 study will compare intermittent hormone therapy (standard arm) alone or combined with salvage pelvic radiotherapy (experimental arm). PMID: 28847462 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/28847462?dopt=Abstract

Source: Cancer Radiotherapie - August 25, 2017 Category: Cancer & Oncology Authors: Supiot S, Doré M, Rio E Tags: Cancer Radiother Source Type: research